Nicotinic antagonists (piperidines and quinuclidines) reduce the susceptibility of early sea urchin embryos to agents evoking calcium shock

General Pharmacology

Volumn 29, Issue 1, 1997, Pages 49-53

  Buznikov, G A ^a   Koikov, L N ^b   Shmukler, Yu B ^a   Whitaker, M J ^c  

^a KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

^b Center for Drug Chemistry   (Russian Federation)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Early embryos; Nicotinic choline receptors

Indexed keywords

DICHOLINE SUBERATE DIIODIDE; IONOMYCIN; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PIPERIDINE DERIVATIVE; QUINUCLIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SEA URCHIN;

ANIMALS; CALCIUM; EMBRYO, NONMAMMALIAN; IONOMYCIN; IONOPHORES; NICOTINIC ANTAGONISTS; PEMPIDINE; QUINUCLIDINES; RECEPTORS, NICOTINIC; SEA URCHINS;

EID: 0030909305     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00524-1     Document Type: Article

References (28)

1. Barlow R. B. (1964) Introduction to Chemical Pharmacology. 2nd ed. Methuen, London.
2. Brehteric L., Lee G. E., Lunt E., Wragg W. R. and Edge N. D. (1959) Congeners of pempidine with high ganglion-blocking activity. Nature (London) 184, 1707-1709.
3. Buznikov G.A. (1984) The action of neurotransmitters and related substances on early embryogenesis. In Developmental Pharmacology (Edited by Papp J. Gy.), pp. 23-59. Pergamon Press, London.
4. Buznikov G. A. (1990) Neurotransmitters in Embryogenesis. Harwood Academic Press, Chur, Switzerland.
5. Buznikov G. A. (1991) The biogenic monoamines as regulators of early (pre-nervous) embryogenesis: new data. In Plasticity and Regeneration of the Nervous System (Edited by Timiras P. S., Privat A., Giacobini E. and Lauder J.), pp. 33-48. Plenum, New York; London.
6. Buznikov G. A., Martynova L. E., Marshak T. L., Galanov A. Yu., Dungenova R. E., Nikitina L. A., Mileusnic R. and Rakic L. (1993a) The effect of protein kinase C activators and inhibitors MA on early echinoderm embryos. Russ. J. Dev. Biol. 24, 172-181.
7. Buznikov G. A., Nikitina L. A., Galanov A. Yu., Malchenko L. A. and Trubnikova O. B. (1993b) The control of oocyte maturation in the starfish and amphibians by serotonin and its antagonists. Int. J. Dev. Biol. 37, 363-364.
8. Buznikov G. A. and Podmarev V. G. (1990) Sea urchins Strongylocentrotus droebachiensis, S. Nudus, S. intermedius. In Animals species for developmental studies (Edited by Detlaf T. A. and Vassetzky S. G.), Vol. 1, Invertebrates, pp. 253-285. Consultants Bureau, New York; London.
9. Buznikov G. A., Shmukler Yu. B. and Lauder J. M. (1996) From oocyte to neuron: do neurotransmitters function in the same way throughout development? Mol. Cell. Neurobiol. 16, 532-559.
10. Chodera A., Frencel I. and Szpunar K. (1964) Die pharmakologischen Eigenschaften des Triacetonamins. Pharm. Zentralhalle 103, 17-23; Chem. Abstr. 61, 2364g.
11. Chodera A., Frencel I. and Szpunar K. (1964) Die pharmakologischen Eigenschaften des Triacetonamins. Pharm. Zentralhalle 103, 17-23; Chem. Abstr. 61, 2364g.
12. Falugi C. (1993) Localization and possible role of molecules associated with the cholinergic system during "non-nervous" development events. Eur. J. Histochem. 37, 287-294.
13. Frachey G., Gionta G. and Lillock C. (1993) Ring-opening reactions VII: ring-size effect on the reactivity of 1,1,2,2,w,w-hexamethyl cyclic ammonium ions in the exocyclic elimination reaction. Gazz. Chim. Ital. 123, 463-466.
14. Gilmore J., Bowman D. and Lodge D. (1995) Neuronal calcium channels. Annu. Rep. Med. Chem. 30, 51-60.
15. Hall H. K., Jr. (1957) Steric effects on the base strengths of cyclic amines. J. Am. Chem. Soc. 79, 5444-5447.
16. Lingle C. (1983) Different types of blockade of crustacean acetylcholine-induced currents. J. Physiol. (London) 339, 419-437.
17. Mashkovsky M. D., Yachontov L. N., Kaminka M. E. and Mikhlina E. E. (1983) Further development in research on the chemistry and pharmacology of synthetic quinuclidine derivatives. Prog. Drug Res. 27, 9-61.
18. McDonald I., Cosford N. and Vernier, J.-M. (1995) Nicotinic acetylchoine receptors: molecular biology, chemistry and pharmacology. Annu. Rep. Med. Chem. 30, 41-50.
19. Michelson M. J. (1973) Pharmacology of cholinergic systems in some other phyla. In Comparative Pharmacology (Edited by Michelson M. J.), Vol. 1, pp. 191-229. Pergamon Press, Oxford, New York.
20. Navajas C. C., Montero L. A. and La Serna B. (1990) Theoretical models for the conformations and protonation of triacetonamine. J. Comput.-Aided Mol. Des. 4, 403-409.
21. Nikiskaya E. S., Arutjunjan G. S., Mashkovsky M. D. and Yachontov L. N. (1974) Synthesis and pharmacological study of 2,2,6,6-tetramethyl-4-aryl(aralkyl)aminipiperidine derivatives. Khim.-Farm. Zh. 8, 16-21.
22. Papke R. L., Craig A. G. and Heinemann S. F. (1994) Inhibition of nicotinic acetylcholine receptors by bis(2,2,6,6-tetramethyl-4-piperidinyl) sebacate (Tinuvin 770): an additive to medical plastics. J. Pharmac. Exp. Ther. 268, 718-726.
23. Rozantsev E. G., Kagan E. Sh. and Sholle V. D. (1992) Triacetonamine in the chemistry of nitroxyl radicals. In Bioactive Spin Labels (Edited by Zhdanov R. I.), pp. 83-118. Springer Verlag, Berlin.
24. Triggle D. J. and Triggle C. R. (1976) Chemical Pharmacology of the Synapse. Academic Press, London.
25. Van Rossum J. M. (1962) Classification and molecular pharmacology of ganglionic blocking agents II: mode of action of competetive and non-competitive ganglion-blocking agents. Int. J. Neuropharmac. 1, 403-422.
26. Yazaki I., Tosti E. and Dale B. (1995) Cytoskeletal elements link calcium channel activity and the cell cycle in early sea urchin embryos. Development 121, 1827-1831.
27. Xu Sh., Wang Zh., Feng J., Lin Y. and Long K. (1988) Effects of triacetonamine-HCl on myocardial transmembrane potentials I: the antiarrhythmic mechanism of triacetonamine. Zhongshan Daxue Xuebao, Ziran Kexueban, No. 4, 89-96; Chem. Abstr. 110, 205-354.
28. Xu Sh., Wang Zh., Feng J., Lin Y. and Long K. (1988) Effects of triacetonamine-HCl on myocardial transmembrane potentials I: the antiarrhythmic mechanism of triacetonamine. Zhongshan Daxue Xuebao, Ziran Kexueban, No. 4, 89-96; Chem. Abstr. 110, 205-354.